Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
   
Ask the Experts About

Hepatitis and HIV CoinfectionHepatitis and HIV Coinfection
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Feeling Great!
Mar 28, 2002

Ihave hepatitis C. Genotype 1 with level 3 cirrhosis damage. I feel great and have no symptoms. My specialist wants me to do the Peg-Intron treatment. Should I wait for the Pegasys treatment to become available?

Response from Dr. Rodriguez-Torres

I am happy you feel well.!!Unfortunately, most patients with chronic HCV are asymptomatic ,and this does not means that they will not have to be concerned about this disease.If you have HCV with genotype 1,and moderate fibrosis,only if you have a low viral load,less than 2 million copies,you may expect the same efficacy,from Peg Intron as compared to Rebetron.Even in this group,the responses with Pegasys and RBV are better.If you have high viremia,you should definitely wait for Pegasys. We expect this drug to be available in the next months. Good luck.!!



Previous
tattoos
Next
pain on right side

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement